We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Gives Green Light to Takeda’s Ninlaro for Multiple Myeloma
FDA Gives Green Light to Takeda’s Ninlaro for Multiple Myeloma
The FDA has given Takeda’s Ninlaro the green light of approval in combination with other therapies to treat multiple myeloma in the second-line setting.